Strategic Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Strategic Asset Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$71K	Buy	1,500 +61	+4%	+$3.17K	0.12%	117
2022 Q2	$73K	Buy	1,439 +20	+1%	+$1.09K	0.12%	121
2022 Q1	$86K	Buy	1,419 +20	+1%	+$1.19K	0.12%	113
2021 Q4	$92K	Sell	1,399 -1,787	-56%	-$114K	0.13%	102
2021 Q3	$201K	Buy	+3,186	New	+$203K	0.28%	58

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Strategic Asset Management's IHI Position: Q3 2022 in Review

Strategic Asset Management increased its iShares US Medical Devices ETF (IHI) stake by 4.2% in Q3 2022, buying an estimated $3.17K and bringing the position to 1,500 shares worth $71K. The position accounts for 0.12% of the portfolio, ranked #117.

Strategic Asset Management first reported a position in IHI in Q3 2021 and has held it in 5 quarters since. The position peaked at $201K in Q3 2021. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

Strategic Asset Management held 1,500 shares of iShares US Medical Devices ETF worth $71K as of Q3 2022.
Strategic Asset Management bought 61 iShares US Medical Devices ETF shares in Q3 2022, an estimated $3.17K.
iShares US Medical Devices ETF made up 0.12% of Strategic Asset Management's portfolio in Q3 2022, its #117 holding.
Strategic Asset Management first reported a position in iShares US Medical Devices ETF in Q3 2021 and has held it in 5 quarters since.
Strategic Asset Management's iShares US Medical Devices ETF position peaked at $201K in Q3 2021.
556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on Strategic Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.